Global Phase Study Lead, Clinical Operations
Listed on 2026-11-01
-
Research/Development
Clinical Research -
Healthcare
Clinical Research
Akero Therapeutics, a Novo Nordisk company, seeks a seasoned Clinical Operations leader to serve as Global Study Lead for a large Phase 3 trial in metabolic disease. You will oversee start-up, enrollment, site management, and CRO partnerships, ensuring quality and regulatory readiness.
This role demands 8+ years in clinical research, strong leadership, and experience with CRO oversight and global study execution. Travel up to 25% and collaboration across functional teams are required.
We are looking to fill the Global Phase 3 Study Lead, Clinical Operations position at akerotherapeutics in United States.
Learn more about the Global Phase 3 Study Lead, Clinical Operations role in the description above.
We appreciate your interest in this position.
Join akerotherapeutics and contribute to our ongoing work.
Take a moment to read everything above and see whether this role is right for you.
(If this job is in fact in your jurisdiction, then you may be using a Proxy or VPN to access this site, and to progress further, you should change your connectivity to another mobile device or PC).